Yuyi Feng
Overview
Explore the profile of Yuyi Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feng Y, Qiu D, He Y, Jin H, Chen L, Xi F, et al.
Front Pharmacol
. 2025 Jan;
15:1502349.
PMID: 39872052
Introduction: Tumor tissues exhibit significantly lower oxygen partial pressure compared to normal tissues, leading to hypoxia in the tumor microenvironment and result in resistance to tumor treatments. Strategies to mitigate...
2.
Qiu D, He Y, Feng Y, Lin M, Lin Z, Zhang Z, et al.
Front Oncol
. 2024 Aug;
14:1424824.
PMID: 39091919
The tumor microenvironment is increasingly acknowledged as a critical contributor to cancer progression, mediating genetic and epigenetic alterations. Beyond diverse cellular interactions from the microenvironment, physicochemical factors such as tumor...
3.
Yang J, Dong X, Jin S, Wang S, Wang Y, Zhang L, et al.
Acad Radiol
. 2024 Jul;
32(1):146-156.
PMID: 39025700
Rationale And Objectives: To develop and validate a clinical-radiomics model of dynamic contrast-enhanced MRI (DCE-MRI) for the preoperative discrimination of Vessels encapsulating tumor clusters (VETC)- microvascular invasion (MVI) and prognosis...
4.
He Y, Feng Y, Qiu D, Lin M, Jin H, Hu Z, et al.
J Drug Target
. 2024 Jun;
32(8):964-976.
PMID: 38884143
Numerous nanomedicines have been developed recently that can accumulate selectively in tumours due to the enhanced permeability and retention (EPR) effect. However, the high interstitial fluid pressure (IFP) in solid...
5.
Liu L, Wang Q, Zhao X, Huang Y, Feng Y, Zhang Y, et al.
Front Oncol
. 2023 Mar;
13:1131892.
PMID: 36890811
Introduction: As one of the most common malignant tumors in clinical practice, hepatocellular carcinoma (HCC) is a major threat to human health, where alpha-fetoprotein (AFP) is widely used for early...
6.
Jiang L, Jia Y, Wang X, Wang Z, Lv X, Jia Y, et al.
Expert Opin Drug Saf
. 2023 Jan;
22(5):407-416.
PMID: 36608279
Background: This study aimed to evaluate the efficacy and safety of dapagliflozin as a monotherapy glucose-lowering drug treatment for older adults with diabetes. Research Design & Methods: Randomized controlled trial...
7.
Jia Y, Wang Z, Feng Y, Wang M, Jiang L, Yu Z, et al.
Steroids
. 2022 Jul;
186:109086.
PMID: 35803387
Quantification of endogenous steroids and their precursors is essential for diagnosis of a wide range of causes for female infertility. However, immunoassays often overestimate concentrations due to assay interference by...
8.
Xi F, Feng Y, Chen Q, Chen L, Liu J
Front Oncol
. 2022 Jul;
12:942496.
PMID: 35785177
[This corrects the article .].
9.
Xi F, Feng Y, Chen Q, Chen L, Liu J
Front Oncol
. 2022 May;
12:852454.
PMID: 35558507
Sonodynamic therapy (SDT) is a promising treatment method for solid tumors. However, the high interstitial fluid pressure (IFP) in tumor tissues limits the accumulation of sonosensitizers. In the present study,...
10.
Wang Z, Wang X, Wang Z, Feng Y, Jia Y, Jiang L, et al.
JAMA Netw Open
. 2021 Jul;
4(7):e2120165.
PMID: 34292334
Importance: Although BCR-ABL fusion oncoprotein tyrosine kinase inhibitors (BCR-ABL TKIs) can substantially improve the survival rate of chronic myeloid leukemia (CML), they are clinically accompanied by severe hepatotoxicity. Objective: To...